関連する実験動画

Updated: Nov 21, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.6K

小児ニューロブラストーマのCAR- T 治療試験における異なった結果

Jennifer Abbasi

    JAMA
    |January 12, 2021
    PubMed
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
    05:22

    Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

    Published on: February 24, 2023

    3.8K
    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
    09:06

    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

    Published on: November 11, 2021

    2.8K

    関連する実験動画

    Last Updated: Nov 21, 2025

    Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
    09:34

    Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

    Published on: February 17, 2022

    3.6K
    Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
    05:22

    Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

    Published on: February 24, 2023

    3.8K
    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
    09:06

    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

    Published on: November 11, 2021

    2.8K

    関連する概念動画

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    3.5K
    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.5K
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    JoVEについて
    概要リーダーシップブログJoVEヘルプセンター
    著者向け
    出版プロセス編集委員会範囲と方針査読よくある質問投稿
    図書館員向け
    推薦の声購読アクセスリソース図書館諮問委員会よくある質問
    研究
    JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
    教育
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
    利用規約
    プライバシーポリシー
    ポリシー
    Jove
    Visualize
    お問い合わせ